The Role of In Vivo and Ex Vivo Diagnostic Tools in Severe Delayed Immune-Mediated Adverse Antibiotic Drug Reactions-Reference-Cited by-同舟云学术

The Role of In Vivo and Ex Vivo Diagnostic Tools in Severe Delayed Immune-Mediated Adverse Antibiotic Drug Reactions

Published:2021-05 Issue:5 Volume:9 Page:2010-2015.e4
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Copaescu Ana,Mouhtouris Effie,Vogrin Sara,James Fiona,Chua Kyra Y.L.,Holmes Natasha E.,Douglas Abby,Slavin Monica A.,Cleland Heather,Zubrinich Celia,Aung Ar Kar,Goh Michelle S.Y.,Phillips Elizabeth J.,Trubiano Jason A.

Funder

Austin Medical Research Foundation

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference19 articles.

1. Severe cutaneous adverse reactions related to systemic antibiotics;Lin;Clin Infect Dis,2014

2. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions;Barbaud;Br J Dermatol,2013

3. Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity;Konvinse;Curr Opin Infect Dis,2016

4. The combined utility of ex vivo IFN-gamma release enzyme-linked immunoSpot assay and in vivo skin testing in patients with antibiotic-associated severe cutaneous adverse reactions;Trubiano;J Allergy Clin Immunol Pract,2018

5. Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: delayed skin test and ELISPOT assay results allow the identification of the culprit drug;Bensaid;J Allergy Clin Immunol,2012

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-IgE-mediated drug-induced hypersensitivity reactions in pediatrics;Current Opinion in Pediatrics;2024-08-20

2. Cephalosporin Allergy: Updates on Diagnostic Testing;Current Allergy and Asthma Reports;2024-08-14

3. The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) – Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions;World Allergy Organization Journal;2024-08

4. Severe cutaneous adverse reactions;Nature Reviews Disease Primers;2024-04-25

5. Medical algorithm: Diagnosis and treatment of drug reaction with eosinophilia and systemic symptoms in adult patients;Allergy;2024-04-08